字号·· | 护眼
国会山报

参议院委员会为特朗普的FDA提名人安排关键投票Senate committee sets key vote for Trump FDA nominee

点「原文对照」整页切到原文,或双击某段只看那段的原文。

海蒂·奥弗顿,特朗普总统提名的食品和药物管理局(FDA)局长人选Heidi Overton, President Trump's nominee for the Commissioner of Food and Drugs (FDA)

参议院卫生委员会已安排下周就海蒂·奥弗顿博士出任美国食品药品监督管理局(FDA)局长一事进行关键投票,尽管她的前路并无保证。根据该委员会的一份新闻稿,对奥弗顿提名的投票定于11月18日举行。委员会还将就詹姆斯·奥尼尔出任美国国家科学基金会主任的提名进行投票。在中期选举中遭遇重大失利后,共和党人正赶在民主党人明年掌权之前,尽可能多地确认特朗普总统的提名人选。

The Senate health committee scheduled a key vote next week for Dr. Heidi Overton to serve as commissioner of the Food and Drug Administration (FDA), even as her path forward is not assured. According to a committee press release, the vote on Overton’s nomination is scheduled for Nov. 18. The committee will also vote on James O’Neill’s nomination to serve as director of the National Science Foundation. After suffering a significant electoral defeat in the midterm elections, Republicans are racing to confirm as many of President Trump’s nominees before Democrats take power next year.

但奥弗顿的提名在选举前就已根基不稳,目前尚不清楚选举失利是否足以说服持怀疑态度的共和党参议员推进投票。共和党在该委员会仅占一票多数,因此如果所有民主党人都反对,只要失去一名成员就足以使提名失败。委员会主席、路易斯安那州共和党参议员比尔·卡西迪表示,他周二与奥弗顿会面,但对她的提名和奥尼尔的提名都仍未拿定主意。

But Overton’s nomination was on shaky ground before the election and it’s not clear if losing is enough to convince skeptical GOP senators to proceed with a vote. Republicans have just a single vote majority on the panel, so losing just one member would be enough to sink the nomination if all Democrats oppose it. Committee chairman Bill Cassidy (R-La.) said he met with Overton on Tuesday but remained undecided on both her nomination and O’Neill’s.

在X平台上的一则帖子中,卡西迪似乎将这两项提名与卫生部长小罗伯特·F·肯尼迪为争取卡西迪支持其确认而作出的承诺联系起来,而这些承诺此后已被违背。卡西迪周三在X上写道:“过去几个月里,我与奥弗顿博士和奥尼尔先生就他们的愿景、角色,以及由于政府内其他官员违背承诺和不负责任的决策而存在的信任缺失,进行了几次坦率的交谈。我感谢他们持续坦诚的交流。”

卡西迪还写道:“虽然我对他们两人的提名仍未拿定主意,也知道委员会中其他共和党成员同样尚未决定,但委员会正推进发出他们的审议通知,希望在本届国会以某种方式解决他们的前路问题。”

In a post on X, Cassidy seemingly tied the nominations to promises health secretary Robert F. Kennedy Jr. made to secure Cassidy’s support for his confirmation, which have since been broken. “Over the last several months, I have had several frank conversations with both Dr. Overton and Mr. O’Neill about their visions, roles, and the lack of trust that exists due to broken promises and irresponsible decisions from other officials within the Administration. I appreciate their ongoing candid conversations,” Cassidy wrote on X Wednesday, “While I remain undecided on both of their nominations and am aware that other Republican members of the Committee are undecided as well, the Committee is moving forward with noticing their markup in the hopes of resolving their path forward one way or another this Congress,” Cassidy added.

卡西迪是一名医生,此前曾批评奥弗顿参与特朗普政府削减儿童疫苗接种的努力,称这“几乎足以取消资格”。他表示,奥弗顿必须否定特朗普的言论,才能获得他的投票。这位路易斯安那州参议员已多次试图让政府的卫生提名人承诺维护科学标准、不颠覆疫苗政策,但收效甚微。正是他的关键一票让肯尼迪得以出任卫生与公众服务部部长。

Cassidy, a physician, previously criticized Overton’s involvement in the Trump administration’s efforts to roll back childhood vaccination, calling it “almost disqualifying.”He indicated Overton would need to repudiate Trump’s comments to secure his vote. The Louisiana senator has repeatedly tried to extract promises from administration health nominees to uphold scientific standards and not upend vaccine policy, to little avail. He was the deciding vote that allowed Kennedy to become HHS secretary.

特朗普提名的FDA人选是白宫国内政策高级顾问,此前曾在一家保守派智库担任首席政策顾问。她参与了政府的多项卫生举措,包括一项旨在减少推荐儿童疫苗数量的行政令。奥弗顿称该行政令“具有历史意义”,并曾与特朗普一同站在椭圆形办公室,特朗普在那里谎称麻腮风联合疫苗可能“相当致命”。如果提名获得确认,奥弗顿将接手FDA对堕胎药米非司酮的安全审查。

Trump’s FDA pick is a top domestic policy adviser at the White House and a former chief policy adviser at a conservative think tank. She worked on a variety of administration health initiatives, including an executive order to reduce the number of recommended childhood vaccines. Overton called that order “historic” and stood beside Trump in the Oval Office, where he falsely claimed that the combined MMR shot could be “quite lethal.”If confirmed, Overton would inherit FDA's safety review of the abortion pill mifepristone.

奥弗顿公开反对堕胎,并将2022年最高法院推翻罗诉韦德案的裁决称为“生命界的巨大胜利”。在9月的确认听证会上,奥弗顿不愿直接说明她是否认为米非司酮是安全的。反堕胎组织苏珊·B·安东尼美国反堕胎组织本周发起了一场施压运动,呼吁共和党参议员反对奥弗顿的提名,除非政府立即停止邮购米非司酮,并且FDA纠正其对米非司酮的安全审查——“这一审查已严重偏离正轨”。

Overton is openly anti-abortion and described the 2022 Supreme Court ruling overturning Roe v. Wade as “a huge victory for life.”During her confirmation hearing in September, Overton wouldn’t say directly whether she believes mifepristone is safe. Anti-abortion group Susan B. Anthony Pro-Life America launched a pressure campaign this week calling on GOP senators to oppose Overton’s nomination unless the administration stops mail-order mifepristone immediately and the FDA fixes its safety review of mifepristone “which is wildly off track.”

奥弗顿上周意外成为关注焦点,起因是前卫生与公众服务部高级顾问、肯尼迪的亲密盟友卡利·米恩斯在乔·罗根的播客上公开谈论他认为正在阻碍“让美国再次健康”运动议程的特朗普政府成员,其中就包括奥弗顿。

Overton was unintentionally in the spotlight last week when Calley Means, a former senior HHS adviser and close ally of Kennedy, went on Joe Rogan’s podcast to speak out about members of the Trump administration — including Overton — he viewed as blocking the Make America Healthy Again movement agenda.

阅读媒体原文 ↗